Su Yu

Su Yu is a seasoned professional in regulatory affairs and CMC (Chemistry, Manufacturing, and Controls), currently serving as Senior Director of Regulatory Affairs CMC at Neurogene Inc. since January 2023. Prior experience includes Senior Director of Regulatory CMC at Innovent Biologics from September 2021 to December 2022, Associate Director of Regulatory CMC at Reata Pharmaceuticals in 2020, and a long tenure at AbbVie from 2000 to 2020 where roles included Manager/Senior Manager of Regulatory Affairs CMC and Senior Scientist/Principal Scientist in Process Chemistry. Su Yu's academic foundation is a PhD in Chemistry from the University of Tennessee, Knoxville, earned in 1998, alongside earlier research as a Postdoctoral Researcher at the University of Chicago from 1998 to 2000.